Allen Biopharma Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.06 Cr
as on 13-12-2024
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13.91%
(FY 2022)
- Profit 263.59%
(FY 2022)
- Ebitda -31.85%
(FY 2022)
- Net Worth 49.20%
(FY 2022)
- Total Assets 11.86%
(FY 2022)
About Allen Biopharma
The Corporate was formerly known as Allen S (India) Marketing Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gobinda Saha, Sulakshmi Sarkar, and Gour Sarkar serve as directors at the Company.
- CIN/LLPIN
U51397WB1988PLC043599
- Company No.
043599
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jan 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Allen Biopharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gobinda Saha  | Director | 20-May-2010 | Current |
| Sulakshmi Sarkar | Director | 25-Mar-2022 | Current |
| Gour Sarkar | Director | 24-Oct-2002 | Current |
Financial Performance of Allen Biopharma.
Allen Biopharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.91% increase. The company also saw a substantial improvement in profitability, with a 263.59% increase in profit. The company's net worth Soared by an impressive increase of 49.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allen Biopharma?
In 2021, Allen Biopharma had a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Allen Healthcare Co LimitedActive 30 years 6 monthsGobinda Saha, Sulakshmi Sarkar and 1 more are mutual person
Allen Ad & Publicity Private LimitedActive 27 years 3 monthsGobinda Saha, Sulakshmi Sarkar and 1 more are mutual person
Allen Ayur India Private LimitedActive 31 years 1 monthGobinda Saha, Sulakshmi Sarkar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Allen Biopharma?
Allen Biopharma has a workforce of 35 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allen Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allen Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
